¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"anchorage dependent growth"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® IDDM(Insulin-Dependent Diabetes Mellitus) ÇÑ±Û Àν¶¸°ÀÇÁ¸´ç´¢º´
¼³¸í   
  IDDMÀº ´ç´¢º´ÀÇ Ä¡·á¿¡ ¹Ýµå½Ã Àν¶¸°ÀÌ ÇÊ¿äÇÑ °æ¿ì¸¦ ¸»ÇÑ´Ù. ÁַΠ¿øÀÎÀÌ ÀÌÀÚ¿¡ Àִ Àν¶¸°À» ºÐºñÇϴ ¼¼Æ÷ÀÇ ÆÄ±«À̸ç À̷ΠÀÎÇØ¼­ ´ç´¢º´ÀÇ Ä¡·áÁ¦·Î ¾²À̴ Àν¶¸°ÀÇ ºÐºñ¸¦ ÃËÁøÇϴ ¾à¹°ÀÌ ÀÌ IDDM¿¡¼­´Â ¾²ÀÏ ¼ö°¡ ¾ø°í ¿ÀÁ÷ Àν¶¸°¸¸ÀÌ Ä¡·áÁ¦·Î ¾µ ¼ö°¡ ÀÖ´Ù. ÀüÇüÀûÀΠÀν¶¸° ÀÇÁ¸Çü ´ç´¢º´Àº ¼Ò¾Æ¿¡¼­ ÈçÈ÷ ¹ß»ýÇϰí Àν¶¸° ºÐºñ¼¼Æ÷ÀÇ ÆÄ±«¿¡ ÀÇÇØ¼­ Àν¶¸° ºÐºñ´ÉÀº °ÅÀÇ ¾ø´Ù.
¿µ¹® growth hormone ÇÑ±Û ¼ºÀåÈ£¸£¸ó
¼³¸í   
  ³úÇϼöü Àü¿±¿¡¼­ ºÐºñµÇ´Â È£¸£¸óÁß Çϳª·Î¼­ ½Ã»óÇϺÎÀÇ ¼ºÀåÈ£¸£¸ó¹æÃâ È£¸£¸ó¿¡ ÀÇÇØ ºÐºñ°¡ ÀڱصǸ砼Ҹ¶Å佺Ÿƾ(somatostatin: ÀÌÀÚ¿¡¼­ ºÐºñµÇ¸ç, ¼ºÀåÈ£¸£¸ó¿¡ ¹Ý´ëµÇ´Â ÀÛ¿ëÀ» ÇÔ)¿¡ ÀÇÇØ ºÐºñ°¡ ¾ïÁ¦µÈ´Ù. ¼ºÀå È£¸£¸ó ¹æÃâ È£¸£¸óÀº µµÆÄ¹Î(dopamine)À¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ¼ºÀå È£¸£¸óÀº ¼¼Æ÷ÀÇ ¼ºÀåÀ» ÃËÁø½ÃŰ¸ç Æ¯È÷ °ñÀÇ ¼ºÀåÀ» ÀÚ±ØÇϴµ¥ ±× ÀÛ¿ëÀº Á÷Á¢ ¼¼Æ÷¿¡ ÀÛ¿ëÇϴ °ÍÀÌ ¾Æ´Ï¶ó °£°ú ±ÙÀ°¿¡ ÀÛ¿ëÇÏ¿© ±×°÷¿¡¼­ ¼Ò¸¶Åä¸ÞµòÀ» »ý¼ºÇϸç ÀÌ ¼Ò¸¶Åä¸ÞµòÀÌ ¼¼Æ÷ÀÇ ¼ºÀåÀ» ÃËÁø½ÃŲ´Ù. ÇÑÆí ¼ºÀå È£¸£¸óÀº ¼ºÀå¿¡ ÇÊ¿äÇÑ ´Ü¹éÁú ÇÕ¼ºÀ» Ç×Áø½ÃŰ°í ¿¡³ÊÁö´Â Áö¹æÀ» ÀÌ¿ëÇÏ¿© ¾ò°ÔÇϹǷΠÁö¹æÀÌ¿ëÈ£¸£¸óÀ̶ó°íµµ ºÒ¸°´Ù. ¼ºÀå È£¸£¸óÀÌ °ú´Ù ºÐºñµÇ¸é °ÅÀÎÁõ, ¸»´Üºñ´ëÁõÀÌ À¯¹ßµÇ¸ç ¼ºÀå È£¸£¸óÀÌ °áÇ̵Ǹ頼ºÀåºÎÁøÀÌ ¿Â´Ù.
¿µ¹® growth factor ÇÑ±Û ¼ºÀåÀÎÀÚ
¼³¸í   
  ¼¼Æ÷ÀÇ ºÐÈ­ ¹× ¼ºÀå¿¡ °ü¿©Çϴ ´Ü¹éÁú. ¼ºÀåÀÎÀڴ Á¤»ó ¼¼Æ÷Áֱ⿡ ÇʼöÀûÀ̱⠶§¹®¿¡ µ¿¹°ÀÇ »ý¸í¿¡ Áß´ëÇÑ ¿ä¼Ò°¡ µÈ´Ù. ¹«¾ùº¸´Ùµµ ¼ºÀåÀÎÀڴ Å¾ÆÀÇ ¹ßÀ°À» Á¶Á¤Çϰí Á¶Á÷ÀÇ À¯Áö ¹× º¸¼ö¿¡ Áß´ëÇÑ ¿ªÇÒÀ» Çϸç, Ç÷±¸ÀÇ »ý¼ºÀ» ÀÚ±ØÇÑ´Ù. ¶ÇÇÑ ¾ÏÀÇ ÁøÇà°úÁ¤¿¡µµ °ü¿©ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anchorage dependent growth
    ºÎÂøÁõ½Ä, ºÎÂø¹ßÀ°
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anchorage independent growth
    ºñºÎÂøÁõ½Ä, ºñºÎÂø¹ßÀ°
  • anchorage
    °íÁ¤
  • stationary anchorage
    ºÎµ¿°íÁ¤
  • antibody-dependent cell-mediated cytotoxicity
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
  • bradycardia dependent bundle branch block
    ´À¸°¸Æ¹ÚÀÇÁ¸´Ù¹ß°¥·¡Â÷´Ü, ¼­¸ÆÀÇÁ¸¼º°¢Â÷´Ü
  • complement-dependent cytotoxicity
    º¸Ã¼ÀÇÁ¸¼¼Æ÷µ¶¼º
  • density dependent inhibition
    ¹ÐµµÀÇÁ¸¾ïÁ¦
  • dependent
    1. ÀÇÁ¸- 2. ÀÇÁ¸¼º 3. Á¾¼ÓÀû
  • dependent drainage
    üÀ§¹è¾×(¹ý)
  • dependent edema
    üÀ§ÀÇÁ¸ºÎÁ¾
  • dependent personality disorder
    ÀÇÁ¸ÀΰÝÀå¾Ö
  • dependent variable
    Á¾¼Óº¯¼ö
  • frequency-dependent
    Á֯ļöÀÇÁ¸Çü
  • hormone dependent
    È£¸£¸óÀÇÁ¸-
  • insulin-dependent
    Àν¶¸°ÀÇÁ¸-
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anchorage
    °íÁ¤
  • stationary anchorage
    ºÎµ¿°íÁ¤
  • growth factor
    ¼ºÀåÀÎÀÚ
  • nerve growth factor
    ½Å°æ¼ºÀåÀÎÀÚ
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
  • transforming growth factor
    Àüȯ¼ºÀåÀÎÀÚ
  • vascular endothelial growth factor
    Ç÷°ü³»ÇǼºÀåÀÎÀÚ
  • growth
    ¼ºÀå, Áõ½Ä
  • intrauterine growth restriction
    Àڱ󻼺ÀåÁö¿¬
  • growth spurt
    ¼ºÀå±ÞÁõ
  • peak growth velocity
    Ãִ뼺Àå¼Óµµ
  • growth zone
    ¼ºÀ屸¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anchorage dependent growth
    ºÎÂøÁõ½Ä, ºÎÂø¹ßÀ°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anchorage independent growth
    ºñºÎÂøÁõ½Ä, ºñºÎÂø¹ßÀ°
  • anchorage
    °íÁ¤
  • stationary anchorage
    ºÎµ¿°íÁ¤
  • antibody-dependent cell-mediated cytotoxicity
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
  • thymus-dependent antigen
    °¡½¿»ùÀÇÁ¸Ç׿ø
  • thymus-dependent area
    °¡½¿»ùÀÇÁ¸±¸¿ª
  • bradycardia dependent bundle branch block
    ´À¸°¸Æ¹ÚÀÇÁ¸°¢Â÷´Ü
  • complement-dependent cytotoxicity
    µµ¿òüÀÇÁ¸¼¼Æ÷µ¶¼º
  • thymus-dependent cell
    °¡½¿»ùÀÇÁ¸¼¼Æ÷
  • dependent
    ¾Æ·¡ÂÊ-, ÀÇÁ¸-, ÀÇÁ¸, ÀÇÁ¸¼º
  • density dependent inhibition
    ¹ÐµµÀÇÁ¸¾ïÁ¦
  • dependent edema
    üÀ§ºÎÁ¾
  • dependent strain
    ÀÇÁ¸ÁÖ
  • dependent variable
    Á¾¼Óº¯¼ö
  • dependent personality disorder
    ÀÇÁ¸ÀΰÝÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reciprocal anchorage
    »ó¹Ý°íÁ¤(ßÓÚãͳïÒ), ±³Á¤(Îìïá).
  • reinforced anchorage
    °¡°­°íÁ¤(ʥ˭ͳïÒ).
  • growth arrest line (=growth recovery line)
    ¼ºÀå Áö¿¬¼±
  • DNA polymerase, RNA dependent
    RNA- ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA polymerase, RNA-dependent
    RNA-ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA-dependent RNA polymerase
    DNA-ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • DNA-dependent RNA polymerase
    DNA-ÀÇÁ¸ RNA ÁßÇÕÈ¿¼Ò
  • NADPH-dependent methemoglobin
    NADH-ÀÇÁ¸¸ÞÆ®Çì¸ð±Û·Îºó
  • NADPH-dependent methemoglobin reductase
    NADH-ÀÇÁ¸¸ÞÆ®Çì¸ð±Û·Îºó ¸®´öŸ¾ÆÁ¦
  • NADPH-dependent oxidase system
    NADPH-ÀÇÁ¸¼º »êÈ­È¿¼Ò°è
  • RNA-dependent DNA polymerase
    RNA-ÀÇÁ¸ DNA ÁßÇÕÈ¿¼Ò
  • T dependent antigen
    TÀÇÁ¸¼ºÇ׿ø
  • adcc(antibody dependent cell mediated cytotoxicity)
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
  • antibody dependent cell mediated cytotoxicity
    Ç×üÀÇÁ¸ ¼¼Æ÷¸Å°³ ¼¼Æ÷µ¶¼º.
  • antigen, thymus-dependent
    Èä¼±ÀÇÁ¸Ç׿ø, °¡½¿»ùÀÇÁ¸Ç׿ø
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anchorage dependent growth
    ºÎÂøÁõ½Ä, ºÎÂø¹ßÀ°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anchorage independent growth
    ºñºÎÂøÁõ½Ä, ºñºÎÂø¹ßÀ°
  • growth arrest line (=growth recovery line)
    ¼ºÀå Áö¿¬¼±
  • anchorage
    °íÁ¤(¼ú)(ͳïÒâú), ¾ÞÄ¿¸®Áö.
  • extramaxillary anchorage
    ¾Ç¿Ü°íÁ¤(¹ý)(äÉèâͳïÒÛö).
  • extraoral anchorage
    ±¸¿Ü°íÁ¤.
  • intramaxillary anchorage
    ¾Ç°£°íÁ¤(äÉÊà ͳïÒ).
  • reciprocal anchorage
    »ó¹Ý°íÁ¤(ßÓÚãͳïÒ), ±³Á¤(Îìïá).
  • reinforced anchorage
    °¡°­°íÁ¤(ʥ˭ͳïÒ).
  • simple anchorage
    ´Ü¼ø°íÁ¤(¡­Í³ïÒ).
  • stationary anchorage
    ºÎµ¿°íÁ¤(ÝÕÔÑͳïÒ).
  • adcc(antibody dependent cell mediated cytotoxicity)
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
  • antibody dependent cell mediated cytotoxicity
    Ç×üÀÇÁ¸ ¼¼Æ÷¸Å°³ ¼¼Æ÷µ¶¼º.
  • antigen, thymus-dependent
    Èä¼±ÀÇÁ¸Ç׿ø, °¡½¿»ùÀÇÁ¸Ç׿ø
  • area, thymus-dependent
    Èä¼±ÀÇÁ¸¿ª, °¡½¿»ùÀÇÁ¸¿ª
  • bradycardia dependent bundle branch block
    ¼­¸ÆÀÇÁ¸¼º °¢Â÷´Ü(ßïØæëîðíàõ ÊÅó´Ó¨).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Appositional growth
    µ¡ºÙÀ̼ºÀå
    [¿¾ ¿ë¾î] ÷°¡¼ºÀå
  • Abnormal growth
    ºñÁ¤»ó¼ºÀå
    [¿¾ ¿ë¾î] ºñÁ¤»ó¼ºÀå
  • Interstitial growth
    »çÀÌÁú¼ºÀå
    [¿¾ ¿ë¾î] °£Áú¼ºÀå
  • Growth abnormality
    ¼ºÀåÀÌ»ó
    [¿¾ ¿ë¾î] ¼ºÀåÀÌ»ó
  • Growth defect
    ¼ºÀå°áÇÔ
    [¿¾ ¿ë¾î] ¼ºÀå°áÇÔ
  • Growth cone
    ¼ºÀå¿ø»Ô
    [¿¾ ¿ë¾î] ¼ºÀå¿øÃß
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anchorage independent growth
    °íÁ¤ºñÀÇÁ¸¼º¼ºÀå(ͳïÒÞªëîðíàõà÷íþ)
  • density-dependent growth
    "¹ÐµµÀÇÁ¸ ¼ºÀå(ÚËÓøëîðíà÷íþ), (ÔÒ) contact inhibition"
  • anchorage dependence
    °íÁ¤ÀÇÁ¸¼º(ͳïÒëîðíàõ)
  • antibody dependent cellular cytotoxicity
    Ç×üÀÇÁ¸ÀÚ¸® ¼¼Æ÷¼º¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øààõá¬øàÔ¸àõ)
  • Ca2+-dependent regulatory protein
    Ca2+-ÀÇÁ¸(ëîðí) Á¶Àý´Ü¹éÁú(ðàï½Ó±ÛÜòõ)
  • calcium-dependent proteinase
    Ä®½·ÀÇÁ¸(ëîðí) ÇÁ·ÎƼ³×À̽º
  • calcium-dependent regulatory protein
    Ä®½·ÀÇÁ¸ Á¶Àý´Ü¹éÁú(ëîðíðàï½Ó±ÛÜòõ)
  • cAMP-dependent protein kinase
    cAMPÀÇÁ¸(ëîðí) ´Ü¹éÁú(Ó±ÛÜòõ) Ȱ¼ºÈ­È¿¼Ò(üÀàõûùý£áÈ)
  • DNA-dependent DNA polymerase
    DNAÀÇÁ¸(ëîðí) DNA Æú¸®¸Ó·¹À̽º
  • DNA-dependent RNA polymerase
    DNAÀÇÁ¸ RNA Æú¸®¸Ó·¹À̽º
  • RNA-dependent (directed) DNA polymerase
    RNA ÀÇÁ¸(ëîðí)(Áö½Ã(ò¦ãÆ)) DNA Æú¸®¸Ó·¹À̽º
  • RNA-dependent (directed) RNA polymerase
    RNA ÀÇÁ¸(ëîðí) (Áö½Ã(ò¦ãÆ)) DNA Æú¸®¸Ó·¹À̽º
  • asynchronous growth
    ºñµ¿½Ã¼º ¼ºÀå (ÞªÔÒãÁàõà÷íþ)
  • balanced growth
    ±ÕÇü¼ºÀå(гû¬à÷íþ)
  • chain-growth polymer
    »ç½½½ÅÀå(ãßíþ)ÁßÇÕü(ñìùêô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • BOLD [=blood oxygenation level dependent]
    Ç÷Áß»ê¼ÒÄ¡ÀÇÁ¸
  • dependent
    °¡¶ó¾ÉÀº, ¾Æ·¡ÂÊÀÇ, ÀÇÁ¸ÀûÀÎ, ºÎ¾ç°¡Á·
  • frequency dependent
    Á֯ļöÀÇÁ¸Çü
  • hormone dependent tumor
    È£¸£¸óÀÇÁ¸¼ºÁ¾¾ç
  • insulin dependent diabetes mellitus
    Àν¶¸°ÀÇÁ¸¼º´ç´¢º´
  • growth
    ¼ºÀå
  • growth abnormality
    ¹ßÀ°ÀÌ»ó
  • growth and development
    ¼ºÀå°ú ¹ßÀ°
  • growth arrest line
    ¼ºÀåÁö¿¬¼±
  • growth curve
    Áõ½Ä°î¼±, ¼ºÀå°î¼±
  • growth hormone
    ¼ºÀåÈ£¸£¸ó
  • growth line
    ¼ºÀå¼±
  • growth retardation
    ¼ºÀåÁö¿¬
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SAI Self-Analysis Inventory; Sexual Arousability Inventory; Social Adequacy Index; suppressor of anchora...
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
NG nasogastric; neoplastic growth; new growth; nitroglycerin; nodose ganglion; no growth; not given
TGF T-cell growth factor; transforming growth factor; tuboglomerular feedback; tumor growth factor
TD tabes dorsalis; tardive dyskinesia; T-cell dependent; temporary disability; terminal device; tetanus...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AIG anchorage independent growth
AI anchorage independent
HB-EGF Heparin binding epidermal growth factor-like growth factor
HB-EGF Heparin-binding epidermal growth factor (EGF)-like growth factor
GH-IGF-I growth hormone-insulin-like growth factor I
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • anchorage independent growth
    ºñºÎÂø Áõ½Ä, ºñºÎÂø ¹ßÀ°
  • IGF-I : insulin like growth factor-IÀÇ ¾àÀÚ. ¼ºÀåÆÇÀÎ epiphyseal plate¿¡ ¿¬°ñ »ý¼ºÀ» Áõ°¡½ÃÄÑ »ÀÀÇ ¼ºÀåÀ» ÃËÁøÇÑ´Ù.

    IGF-II : insulin like growth factor-IIÀÇ ¾àÀÚ. ¸¹Àº Àå±â¿Í Á¶Á÷¿¡ ÀÛ¿ëÇÏ¿© ´Ü¹é ÇÕ¼º°ú DNA, RNAÀÇ ÇÕ¼ºÀ» Áõ°¡½ÃÄÑ ¼¼Æ÷ÀÇ ¼ö¿Í ¾çÀ» Áõ°¡

    Àν¶¸°¾ç ¼ºÀå ÀÎÀÚ °áÇÕ ´Ü¹éÁú
    insulinelike growth factor binding
  • antibody dependent cell mediated cytotoxicity
    Ç×ü ÀÇÁ¸ ¼¼Æ÷ ¸Å°³ ¼¼Æ÷ µ¶¼º, Ç×ü ÀÇÁ¸¼º ¼¼Æ÷ ¸Å°³¼º ¼¼Æ÷ µ¶¼º
  • dependent edema
    Á߷¼º ºÎÁ¾
    ÇÇÇÏ Á¶Á÷¿¡ »ý±ä ºÎÁ¾Àº ½ÉºÎÀü, ƯÈ÷ ¿ì½ÉºÎÀü¿¡¼­ÀÇ Æ¯Â¡ÀûÀÎ ¼Ò°ßÀε¥, ¿ì½ÉºÎÀüÀÌ ÀÖÀ» ¶§ ½ÉÀåÀ¸·Î °¡´Â Á¤¸ÆÇ÷ ȯ·ùÀÇ Àå¾Ö°¡ Àü½ÅÀûÀ¸·Î ¿µÇâÀ» ¹ÌÄ¡³ª ºÎÁ¾Àº ³ôÀº Á¤¼ö¾Ð¿¡ ÀÇÇØ »ý±â±â ¶§¹®¿¡ ÇÏÁö¿¡ ƯÈ÷ ½ÉÇÏ°Ô ¿Â´Ù. ȯÀÚ°¡ ´©¿ö ÀÖÀ» ¶§´Â õÃß ºÎÀ§¿¡ ºÎÁ¾ÀÌ »ý±ä´Ù. ºÎÁ¾ÀÇ ºÐÆ÷°¡ ÀÌó·³ Áß·ÂÀÇ ¿µÇâÀ» ¹Þ´Â °ÍÀ» Á߷¼º ºÎÁ¾À̶ó°í ÇÑ´Ù.
  • dependent personality disorder
    ÀÇÁ¸¼º ÀÎ°Ý Àå¾Ö
  • dependent strain
    ÀÇÁ¸ÁÖ
  • hormone dependent tumor
    È£¸£¸ó ÀÇÁ¸¼º Á¾¾ç
  • insulin dependent diabetes mellitus
    Àν¶¸° ÀÇÁ¸¼º ´ç´¢º´
  • passive dependent
    Çǵ¿ ÀÇÁ¸¼º. ¼öµ¿ ÀÇÁ¸¼ºÀÇ
  • rate dependent bundle branch block
    ½É¹Ú ¼ö ÀÇÁ¸¼º °¢ Â÷´Ü
  • thymus-dependent cell
    Èä¼± ÀÇÁ¸ ¼¼Æ÷
  • anchorage
    °íÁ¤, °íÁ¤¼ú, ¾ÞÄ¿¸®Áö
    º¯À§µÈ Àå±âÀÇ ¿Ü°úÀû °íÁ¤°ú °°Àº °íÁ¤, Ä¡°ü ¼öº¹Çп¡¼­ ÃæÀü¹° ¶Ç´Â Àΰø Ä¡°ü°ú °¡°øÀÇÄ¡ÀÇ °íÁ¤, Ä¡¿­ ±³Á¤¼ú¿¡¼­ ÀåÄ¡¸¦ Á¶ÀýÇϱâ À§ÇÑ °¢Á¾ °íÁ¤.
  • compound anchorage
    º¹ÇÕ °íÁ¤
    µÎ °³ ȤÀº ±× ÀÌ»óÀÇ Ä¡¾Æ·ÎºÎÅÍ ÀúÇ×À» ¹Þ´Â ±³Á¤ °íÁ¤.
  • extaroral anchorage
    ±¸°­¿Ü °íÁ¤
    ¾Ç¿Ü °íÁ¤¹ý. ÈûÀ» °¡ÇÏ´Â ÀåÄ¡°¡ ±¸°­ ¿Ü¿¡ ÀÖµµ·Ï ÇÏ´Â °íÁ¤. ¿¹ÄÁ´ë µÎºÎ °íÁ¤, ÈĵκΠ°íÁ¤, °æºÎ °íÁ¤ µîÀÌ ÀÖ´Ù.
  • intermaxillary anchorage
    ¾Ç°£ °íÁ¤
    ÀúÇ× ´ÜÀ§°¡ ÇÑ Åο¡ ÀÖ´Â ±³Á¤ °íÁ¤À¸·Î¼­ ´Ù¸¥ ÅÎÀÇ Ä¡¾Æ ¿îµ¿¿¡ ÀÛ¿ë½Ã۱â À§ÇØ »ç¿ëµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
density dependent inhibition of growth <cell culture> The phenomenon exhibited by most normal (anchorage dependent) animal cells in culture that stop dividing once a critical cell density is reached.
The critical density is considerably higher for most cells than the density at which a monolayer is formed, for this reason, most cell behaviourists prefer the term density dependent inhibition of growth as this avoids any confusion with contact inhibition of locomotion, a totally different phenomenon that is contact dependent.
(12 Jan 1998)
anchorage <cell biology> Attachment, not necessarily adhesive in character, because the mechanism is not assumed the term ought to be more widely used.
(18 Nov 1997)
anchorage dependence <cell biology, cell culture> The necessity for attachment (and spreading) in order that a cell will grow and divide in culture.
Loss of anchorage dependence seems to be associated with greater independence from external growth control and is probably one of the best correlates of tumourigenicity in vivo. Anchorage independence is usually detected by cloning cells in soft agarose, only anchorage independent cells will grow and divide (as they will in suspension).
(18 Nov 1997)
reciprocal anchorage Anchorage in which the movement of one or more teeth is balanced against the movement of one or more opposing teeth.
(05 Mar 2000)
reinforced anchorage Anchorage in which more than one type of resistance unit is utilised.
Synonym: reinforced anchorage.
(05 Mar 2000)
cervical anchorage Anchorage in which the back of the neck is used for resistance by means of a cervical strap.
(05 Mar 2000)
multiple anchorage Anchorage in which more than one type of resistance unit is utilised.
Synonym: reinforced anchorage.
(05 Mar 2000)
simple anchorage Anchorage in which the resistance to the movement of one or more teeth comes solely from resistance to tipping movement of the anchorage unit.
(05 Mar 2000)
stationary anchorage Anchorage in which the resistance to the movement of one or more teeth comes from the resistance to bodily movement of the anchorage unit; a questionable concept since the selected teeth remain only relatively stable.
(05 Mar 2000)
intermaxillary anchorage Anchorage in which the units in one jaw are used to effect tooth movement in the other jaw.
(05 Mar 2000)
intramaxillary anchorage Anchorage in which the resistance units are all situated within the same jaw.
(05 Mar 2000)
intraoral anchorage Anchorage in which the resistance units are all located within the oral cavity.
(05 Mar 2000)
occipital anchorage Anchorage in which the top and back of the head are used for resistance by means of a headgear.
(05 Mar 2000)
extraoral anchorage Anchorage in which the resistance unit is outside the oral cavity; e.g., cranial, occipital, or cervical anchorage.
(05 Mar 2000)
aid to families with dependent children Financial assistance provided by the government to indigent families with dependent children who meet certain requirements as defined by the social security act, title IV, in the u.s.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anchorage
    Á¤¹ÚÇÏ´Ù
  • anchorage
    ´éÀ» ³»¸²;Åõ¹¦;Á¤¹Ú;Á¤½ÅÀû ÀÇÁö;ÀºÀÚÀÇ ÁÖ°Å;ÀºµÐó
  • dependent
    ÀÇÁ¸ÇÏ´Â
  • dependent
    =DEPENDENT
  • dependent
    ~¿¡ ÀÇÁöÇϰí ÀÖ´Â;ÀÇÁ¸ÇÏ´Â;~³ª¸§ÀÇ;Á¾¼ÓÀÇ;ÀÇÁ¸ÇÏ´Â »ç¶÷;ºÎ¾ç °¡Á·
  • dependent clause
    Á¾¼ÓÀý !
  • dependent variable
    (¼ö)Á¾¼Ó º¯¼ö 9
  • growth
    ¼ºÀå,¹ß´Þ,Áõ°¡
  • economic growth rate
    °æÁ¦ ¼ºÀå·ü 9
  • growth
    ¼ºÀå;»ýÀå;¹ßÀ°;¹ß´Þ;Áõ´ë;Àç¹è;»ýÀå(¹ß»ý)¹°;»ê¹°
  • growth center
    (sensitivity trainingµîÀ»ÇÏ´Â)´É·Â °³¹ß ¼¾ÅÍ)
  • growth hormone
    ¼ºÀå È£¸£¸ó 
  • growth industry
    ¼ºÀå »ê¾÷
  • growth stock
    ¼ºÀåÁÖ
  • human growth hormone
    Àΰ£¼ºÀå È£¸£¸ó(ÀÎüÀÇ ¼ºÀåÀ» Áö¹èÇÏ´Â ³úÇϼöü Á¾ÇÕ È£¸£¸ó)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á